BioCentury
ARTICLE | Company News

NanoCarrier, Orient Europharma deal

September 30, 2013 7:00 AM UTC

NanoCarrier and Orient signed a memorandum of understanding (MOU) to amend an October 2008 deal granting Orient rights to NanoCarrier's Nanoplatin. Under the MOU, Phase III trials to evaluate Nanopla...